Renoprotection in LEADER and EMPA-REG OUTCOME.
Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, 1081 HV Amsterdam, Netherlands. Electronic address: ma.muskiet@vumc.nl.
Marcel H A
MH
Muskiet
Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, 1081 HV Amsterdam, Netherlands.
Lennart
L
Tonneijck
Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, 1081 HV Amsterdam, Netherlands.
Erik J M
EJ
van Bommel
Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, 1081 HV Amsterdam, Netherlands.
Mark M
MM
Smits
Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, 1081 HV Amsterdam, Netherlands.
Daniël H
DH
van Raalte
D001559:Benzhydryl Compounds; D002318:Cardiovascular Diseases; D003924:Diabetes Mellitus, Type 2; D005960:Glucosides; D006801:Humans; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2
D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2